MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive Function is Preserved 10 Years Following DBS in People with Dystonia

E. Hogg, J. Eskenazi, E. During, J. Wertheimer, R. Alterman, M. Tagliati (Los Angeles, CA, USA)

Meeting: 2017 International Congress

Abstract Number: 1240

Keywords: Cognitive dysfunction, Deep brain stimulation (DBS), Dystonia: Treatment

Session Information

Date: Thursday, June 8, 2017

Session Title: Dystonia

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To study cognitive function in people with dystonia chronically treated with Deep Brain Stimulation (DBS).

Background: The impact of DBS on cognition is a matter of debate. While short follow-up studies have found no significant cognitive changes following DBS for dystonia, the effects of longer stimulation periods remain unknown.

Methods: A telephone survey based on the Montreal Cognitive Assessment (the T-MoCA) was administered to people with dystonia who underwent DBS surgery at least 5 years before study onset. In addition, we analyzed scores from a self-administered survey comparing current day and pre-surgical cognitive function, the 39-item Measurement of Every Day Cognition (Ecog-39). Results were analyzed using a Pearson’s correlation.

Results: 19 people with dystonia treated with DBS (18 GPi, 1 STN) for an average of 10 years (range 5-15 years) completed both T-MoCA and Ecog-39. Average age was 37.5±17.6 years, 9 were female, 14 were DYT1, 1 DYT6, 3 other primary dystonias and 1 secondary dystonia. Average T-MoCA was 20.1±1.9 out of a maximum score of 22 (range 15-22). Only 3 subjects (15.7%) had scores in the impaired range (18 or less), none of which were younger than 30. There was no statistical correlation between age and T-MoCA (r=-0.33, p=0.17). Average overall Ecog-39 score was 1.23±0.32 (range 1.0-2.07). Two subjects (10.5%) scored in the range of concern for impaired cognition (<1.81). There was no statistical correlation between age and Ecog-39 (r=0.05, p=0.87) and between years since DBS surgery and T-MoCA or Ecog score (r=0.08 and r=0.09).

Conclusions: Our results show that cognitive function is preserved in subjects with dystonia treated with DBS for an average of 10 years. Very few subjects reported cognitive concerns. The study was underpowered to show a correlation between age or time from DBS and cognitive scores. Further limitations were the small sample size, self-reporting methodology, and lack of pre-surgical comparison data.

 

Acknowledgments: this study was funded by a DMRF clinical fellowship.

To cite this abstract in AMA style:

E. Hogg, J. Eskenazi, E. During, J. Wertheimer, R. Alterman, M. Tagliati. Cognitive Function is Preserved 10 Years Following DBS in People with Dystonia [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-function-is-preserved-10-years-following-dbs-in-people-with-dystonia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-function-is-preserved-10-years-following-dbs-in-people-with-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley